On May 7, Equities research analysts at Nomura reduced their price objective on shares of YY (NASDAQ:YY) from $114.00 to $104.00 in a research note issued to investors on Monday, Analyst Ratings Net reports. Nomura’s price target points to a potential upside of 83.13% from the stock’s previous close. YY Inc (ADR) (NASDAQ:YY) stock opened today at $62.40 and is currently trading at $61.79. The stock showed a positive weekly performance of 17.40%.
On May 19, Cardtronics Inc (NASDAQ:CATM) Insider Patrick Michael Mccarthy bought 7,800 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $31.84 per share, for a total transaction of $248,352.00. Following the completion of the acquisition, the insider now directly owns 26,316 shares in the company, valued at approximately $837,901. Cardtronics, Inc. (NASDAQ:CATM) stock opened at $31.54, in current trading session and currently is at $31.35, by losing -2.28 %. The 52 week range of $27.04 – $44.46. Company’s market capitalization is $1.40 billion.
On May 22, Royal Gold, Inc (USA) (NASDAQ:RGLD) has earned a consensus rating of “Buy” from the thirteen analysts that are covering the company, American Banking & Market News reports. Five investment analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $69.79. Royal Gold, Inc (USA) (NASDAQ:RGLD) stock is currently trading at $62.30. The EPS of the stock is 0.87. Company’s market capitalization is $4.05 billion.
Durata Therapeutics Inc (NASDAQ:DRTX) said the U.S. Food and Drug Administration has approved DALVANCE for injection for the treatment of adult patients with acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. DALVANCE is the first and only IV antibiotic approved for the treatment of ABSSSI with a two-dose regimen of 1000 mg followed one week later by 500 mg, each administered over 30 minutes. Durata Therapeutics Inc (NASDAQ:DRTX) stock opened the session at $16.07, and now is at $14.65. The 52 week range of the stock remained $6.70 – $17.20 and the day range was $14.61 – $16.32.
Credit Suisse AG – VelocityShares Daily 2x VIX Short Term ETN (NASDAQ:TVIX) stock opened today at $4.41 and is currently trading at $4.37. The stock showed a negative weekly performance of -8.98%.